PG vs TMO: Which Is the Better Buy?
Side-by-side comparison of The Procter & Gamble Company and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
The Procter & Gamble Company · Consumer Defensive
$143.45
+13.8% upside to fair value
Grade B
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$462.60
+10.1% upside to fair value
Grade B
QuantHub Verdict
PG has more upside to fair value
(+13.8%).
PG trades at a lower forward P/E
(20.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
PG |
TMO |
| Current Price |
$143.45 |
$462.60 |
| Fair Value Estimate |
$163.27 |
$509.20 |
| Upside to Fair Value |
+13.8%
|
+10.1%
|
| Market Cap |
$334.0B |
$171.9B |
| Forward P/E |
20.8x
|
25.1x
|
| EV / EBITDA |
15.4x
|
19.0x
|
| Price / Sales |
3.9x
|
3.8x
|
| Price / FCF |
22.2x
|
25.5x
|
| Revenue Growth YoY |
+7.4%
|
+6.2%
|
| Gross Margin |
50.3%
|
39.4%
|
| Operating Margin |
23.2%
|
17.8%
|
| Return on Equity |
31.3%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.5%
|
3.92%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
The Procter & Gamble Company is a leading consumer defensive firm specializing in household and personal products with a diversified portfolio across fabric and home care, baby and family care, beauty, health care, and grooming segments. The business quality is high, supported by durable brands, strong margins with a 50.3% gross margin and 19.2% net margin, and consistent earnings growth evidence…
Thermo Fisher Scientific Inc. operates in the healthcare sector, specializing in medical diagnostics and research tools across four main segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company demonstrates medium business quality with steady revenue growth of 6.2% and earnings growth of 9.6% in the most recent q…
Accumulation Zones
| Metric |
PG |
TMO |
| Zone Low |
$122.45 |
$381.90 |
| Zone High |
$138.78 |
$432.82 |
| In Buy Zone? |
No
|
No
|